acetylcholinesterase/beta amyloid aggregation inhibitors (Nanyang Normal University)

N/A

Report date: 2025/01/26 18:30:37
NME

Base Information

Drug Nameacetylcholinesterase/beta amyloid aggregation inhibitors (Nanyang Normal University)
Drug Alias NameT-22 (Nanyang Normal University/Sichuan University)isobavachromene
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsAcetylcholinesterase inhibitors
TargetsAcetylcholinesteraseBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanyang Normal University
China Registration ClassN/A

Develop Information

Active CompaniesNanyang Normal UniversitySichuan University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A